You are here: Home » News-IANS » Health-Medicine
Business Standard

New low-cost method may provide hope for leukemia patients

IANS  |  London 

Swedish scientists in a breakthrough research have found a highly cost-effective technology which can examine individual cells in leukemia and can eventually transform treatment for patients suffering from the cancer.

The new method helped researchers to examine individual tumour cells in patients with chronic lymphocytic leukemia (CLL) -- a of blood-forming tissues, hindering the body's ability to fight infection.

The finding showed that leukemia tumours are comprised of cells having entirely different gene expressions.

"The study found that CLL cells do not consist of a single cell type, but of a number of sub-clones that exhibit entirely different gene expression," said Joakim Lundeberg, Professor at KTH Royal Institute of Technology in Stockholm, Sweden.

Typically, RNA sequencing will provide information about what RNA molecules are present in a biological sample, but not where or in which cells they are active, the researcher said.

"With this new, highly cost-effective technology, we can now get a whole new view of this complexity within the blood sample. Molecular resolution of single cells is likely to become a more widely-used therapy option," Lundeberg observed.

The method provides analysis of all mRNA molecules in individual cells by binding a location tag to the molecules.

Individual cells are sorted on a specially-made glass surface and using analysis of RNA molecules with next-generation sequencing, one can tell which genes are active.

"With the new method we can study thousands of cells in a day," Lundeberg said, in the paper reported in the journal Nature Communications.

--IANS

rt/sm/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

New low-cost method may provide hope for leukemia patients

Swedish scientists in a breakthrough research have found a highly cost-effective technology which can examine individual cells in leukemia and can eventually transform treatment for patients suffering from the cancer.

Swedish scientists in a breakthrough research have found a highly cost-effective technology which can examine individual cells in leukemia and can eventually transform treatment for patients suffering from the cancer.

The new method helped researchers to examine individual tumour cells in patients with chronic lymphocytic leukemia (CLL) -- a of blood-forming tissues, hindering the body's ability to fight infection.

The finding showed that leukemia tumours are comprised of cells having entirely different gene expressions.

"The study found that CLL cells do not consist of a single cell type, but of a number of sub-clones that exhibit entirely different gene expression," said Joakim Lundeberg, Professor at KTH Royal Institute of Technology in Stockholm, Sweden.

Typically, RNA sequencing will provide information about what RNA molecules are present in a biological sample, but not where or in which cells they are active, the researcher said.

"With this new, highly cost-effective technology, we can now get a whole new view of this complexity within the blood sample. Molecular resolution of single cells is likely to become a more widely-used therapy option," Lundeberg observed.

The method provides analysis of all mRNA molecules in individual cells by binding a location tag to the molecules.

Individual cells are sorted on a specially-made glass surface and using analysis of RNA molecules with next-generation sequencing, one can tell which genes are active.

"With the new method we can study thousands of cells in a day," Lundeberg said, in the paper reported in the journal Nature Communications.

--IANS

rt/sm/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

New low-cost method may provide hope for leukemia patients

Swedish scientists in a breakthrough research have found a highly cost-effective technology which can examine individual cells in leukemia and can eventually transform treatment for patients suffering from the cancer.

The new method helped researchers to examine individual tumour cells in patients with chronic lymphocytic leukemia (CLL) -- a of blood-forming tissues, hindering the body's ability to fight infection.

The finding showed that leukemia tumours are comprised of cells having entirely different gene expressions.

"The study found that CLL cells do not consist of a single cell type, but of a number of sub-clones that exhibit entirely different gene expression," said Joakim Lundeberg, Professor at KTH Royal Institute of Technology in Stockholm, Sweden.

Typically, RNA sequencing will provide information about what RNA molecules are present in a biological sample, but not where or in which cells they are active, the researcher said.

"With this new, highly cost-effective technology, we can now get a whole new view of this complexity within the blood sample. Molecular resolution of single cells is likely to become a more widely-used therapy option," Lundeberg observed.

The method provides analysis of all mRNA molecules in individual cells by binding a location tag to the molecules.

Individual cells are sorted on a specially-made glass surface and using analysis of RNA molecules with next-generation sequencing, one can tell which genes are active.

"With the new method we can study thousands of cells in a day," Lundeberg said, in the paper reported in the journal Nature Communications.

--IANS

rt/sm/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard